Lv1
60 积分 2024-11-05 加入
IBI112, a selective anti-IL23p19 monoclonal antibody, displays high efficacy in IL-23-induced psoriasiform dermatitis
5天前
已完结
Bispecific BCMA/CD19 targeted CAR-T cell therapy forces sustained disappearance of symptoms and anti-acetylcholine receptor antibodies in refractory myasthenia gravis: a case report
7天前
已完结
Combination therapy using the small interfering RNA bevasiranib
17天前
已完结
Recent advances in the bioanalytical methods of polyethylene glycols and PEGylated pharmaceuticals
1个月前
已完结
In vivo CAR T cells move into clinical trials
1个月前
已完结
Extension of in vivo half-life of biologically active molecules by XTEN protein polymers
2个月前
已完结
Pharmacokinetics and absolute bioavailability of mepolizumab following administration at subcutaneous and intramuscular sites
2个月前
已完结
Improvement of pharmacokinetic properties of therapeutic antibodies by antibody engineering
2个月前
已完结
Biomarkers as drug development tools: discovery, validation, qualification and use
4个月前
已完结
Method validation of protein biomarkers in support of drug development or clinical diagnosis/prognosis
4个月前
已完结
皖公网安备34019202002308
